>>> What to look at today - 30/05/2014

US Market Closed Higher despite disap. data, All sectors showed sztrenght but Tech was helped by big names like AAPL +1.8%..defensive sectors like utilities & Telco spent the entire section near flat line...volume were still light @ 532mil shares..lowest volume of the year (533.3 on Jan 3)...VIX @ 11.57 -0.94%...Japan data were mixed with bigger than
expected drop in industrial production balanced by multi-year high CPI figures...In China, the Banking Regulator surmised that the risks in the property sector were controllable, while the PBoC eased up on a trend of softer settings for the currency midpoint rate going into the weekend. On Sunday, China will release its official Manufacturing PMI expected to rise for the 3rd consecutive month...Nikkei -0.16% HS+0.55% Shanghai+0.20%

Eur$ 1.3604 S&P Fut -0.16% European Future Unch - CAC +0.11% ( BNP should be heavily down - shoudl impact CAC)

Macro
- S&P 500, FTSE 100 Year-End Targets Raised at Credit Suisse - S&P 2020 (+5.2% upside) vs 1960 - Ftse 7300 (+6.2% upside) vs 7100 - SX5E 3600 (+11% upside)

Keep an eye on :
- AZA IM : Alitalia/Etihad merger deal only hours away, says Italian Prime Minister
- BNP FP : Justice Dept. Seeks More Than $10 Billion Penalty From BNP Paribas - WSJ
- BOSS GY : Hugo Boss Seeks to Boost Luxury Sales, CEO Tells Handelsblatt
- DAI GY : Super Mario's New Ride Is a Mercedes Benz as Nintendo Expands IP
- DGE LN : Diageo CEO Says Important for Co, Industry to Stay in EU: WSJ
- DTE GY : Deutsche Telekom May Keep Stake After Sale to SoftBank: Reuters
- IHG LN : InterContinental Hotels Cut at SocGen; Good News Priced In
- IHG LN : Activist hedge fund calls on IHG to consider takeover bid
- MAR PL : Martifer 1Q Loss Narrows to EU10.3m Vs Loss of EU14.2m
- NOVN VX : Novartis Must Face Drug Sales Kickback Lawsuit Brought by U.S.
- EGL PL : Mota-Engil 1Q Net Income EU7.3m vs EU5.5m
- QIA GY : Qiagen, Lilly to Collaborate to Co-Develop Companion Diagnostics
- RNO FP : Renault May French Car Registrations Rose 20%, Tribune Says
- RCO FP : BRown Forman rumor - €90/share mentionned refused by families - Daily Mail
- SMDR LN : Cepsa considering €700mil bid for Salamander (500mil for the co +200m debt - so no premium vs yest clos
- SBMO NA : SBM Offshore Has Won No Tenders So Far This Year, Dagblad Says
- SCHP VX : Schindler Sees Extraordinary Profit of CHF75m on Mall Deal in 2Q
- SCVB SS : *SCANIA SAYS VW PROPOSES NO DIVIDEND BE PAID
- SIE GY : Siemens Planning to cut approx 11.6K jobs under cost cutting plan (approx 3% of total workforce)
- GLE FP : SocGen’s Rosbank 1Q Op. Profit EU7m V EU61m in 4Q, Echos Says
- TIT IM : Telecom Italia CEO Patuano Met With GVT Mgmt, Repubblica Says
- TRE SM : Tecnicas Reunidas Wins Contract to Modernize Peru Refinery
- VIV FP : Telecom Italia CEO Patuano Met With GVT Mgmt, Repubblica Says
- VOW3 GY : VW Poised to Accelerate U.S. Product Pace as It Eyes 2018 Goals
- WEIR LN : Could be a takeover target now - GE mentionned as potential suitor (The times & The Telegraph)

>>> Brokers Upgrades & Downgrades

>>> Up
*ANTAM RAISED TO NEUTRAL VS SELL AT UBS
*BPOST SA RAISED TO OVERWEIGHT VS EQUALWEIGHT AT MORGAN STANLEY
*MEDIASET ESPANA RAISED TO NEUTRAL VS UNDERPERFORM AT BOFAML
*MITCHELLS & BUTLERS RAISED TO BUY VS NEUTRAL AT CITI
*NUMERICABLE RAISED TO OUTPERFORM VS NEUTRAL AT EXANE
*PUBLIC POWER RAISED TO BUY VS NEUTRAL AT CITI
*SHANKS GROUP RAISED TO OUTPERFORM VS NEUTRAL AT CREDIT SUISSE

>>> Down
*ANADOLU EFES CUT TO EQUALWEIGHT VS OVERWEIGHT AT MORGAN STANLEY
*AUSTRIAN POST CUT TO UNDERWEIGHT AT MORGAN STANLEY
*BIM CUT TO EQUALWEIGHT VS OVERWEIGHT AT MORGAN STANLEY
*KINGFISHER CUT TO EQUALWEIGHT VS OVERWEIGHT AT BARCLAYS
*LIBERTY GLOBAL CUT TO NEUTRAL VS BUY AT BOFAML
*MMK CUT TO NEUTRAL VS BUY AT CITI
*RUSSIAN STEEL CUT TO NEUTRAL VS OVERWEIGHT AT CITI
*SEVERSTAL CUT TO NEUTRAL VS BUY AT CITI
*TATE & LYLE CUT TO UNDERPERFORM VS NEUTRAL AT CREDIT SUISSE
*VESTAS WIND SYSTEMS CUT TO NEUTRAL VS BUY AT GOLDMAN
*VOESTALPINE CUT TO NEUTRAL VS OVERWEIGHT AT JPMORGAN

>>> PT Change
*Atlantia PT Raised to EU24 at JPMorgan; Kept at Overweight
*Telecom Italia PT Raised to EU0.55 at UBS; Kept at Sell

>>> Initiation
*AMADEUS REINITIATED AT BUY AT KEPLER CHEUVREUX; PT EU36.5
*ATRESMEDIA, TF1, M6 REINSTATED AT NEUTRAL AT BOFAML
*BRAVOFLY RUMBO RATED NEW NEUTRAL AT CREDIT SUISSE, PT CHF48
*CTT RATED NEW EQUALWEIGHT AT MORGAN STANLEY; PT EU7.4
*GECINA RATED NEW HOLD AT BERENBERG; PT EU104
*UBM, LAGARDERE REINSTATED AT UNDERPERFORM AT BOFAML
*REED ELSEVIER, INFORMA, HAVAS REINSTATED AT BUY AT BOFAML
*ROYAL MAIL RATED NEW UNDERWEIGHT AT MORGAN STANLEY; PT 450P

>>> Call
*AKZO NOBEL ENTERS BOFAML LEAST PREFERRED BASIC MATERIALS SHRS
*BNP PARIBAS REMOVED FROM CITI’S FOCUS LIST EUROPE
*RANDGOLD REMOVED FROM UBS’S MOST PREFERRED LIST
*SMITH & NEPHEW ADDED TO UBS’S M&A WATCH LIST
*SOLVAY ADDED TO MOST PREFERRED BASIC MATERIALS SHRS AT BOFAML

(MergerMarket) Allergan seen facing tough fight vs Valeant after improved bid, b

Allergan seen facing tough fight vs Valeant after improved bid, bankers say

Allergan (NYSE: AGN) has a long fight ahead of it as it attempts to fend off uninvited bidder Valeant (NYSE: VRX), said three industry bankers.

In its ongoing battle for Allergan, Valeant increased its takeover bid on 28 May to USD 58.30 and added a contingent value rights plan of up to USD 25 per share for DARPin, Allergan’s Phase II and preclinical drug candidate to treat wet age-related macular degeneration (AMD).

Valeant seems very motivated to buy the Irvine, California-based company, said the first banker. The significant increase in price offered by Valeant speaks to the Canadian firm’s “desperation” to acquire Allergan, added the banker.

Valeant does not have many other options for buys that would fit well with the company as an alternative, said the first banker. In order for Valeant’s business model to work, it must continue to make significant buys, he added. It would be too difficult to do multiple small deals to make up the growth offered by Allergan, said the banker.

Allergan is arguing against the merger in part because Valeant’s model seeks to cut R&D from the combined companies. “The whole industry dislikes what Valeant does. Ultimately, it is not good for people because no new drugs will come to market,” said a third banker. “Lots of people are questioning the strategic rationale of Valeant and how long it can last. It’s feeding itself off acquisitions,” said Todd Munn, PM of The Arbitrage Fund, which is part of the USD 3.6bn Water Island Capital Investment Group.

Allergan may need to conduct a transformative deal of its own in order to argue to its shareholders that the company is better off as a standalone, this banker said. Valeant is here for the long haul, and it is likely to take Allergan to a proxy fight, said two of the bankers.

As the deal has a stock component, Allergan has pointed to several issues with Valeant’s business model that would be detrimental to Valeant’s long-term value. In the new proposal, the deal, which includes 0.83 Valeant shares for each Allergan share, is now valued at around USD 165.5 per share, without factoring in the CVR, based on Valeant's closing price on Thursday of USD 129.22 per share.

These issues included Valeant’s absence of an effective organic growth strategy, decreasing sales following its recent purchases of Bausch & Lomb and Medicis, the likelihood of cost-cutting measures that would hinder Allergan’s operations and R&D efforts, and the high turnover among Valeant’s senior managers.

Allergan can argue to shareholders that it is not in their best interest to be long-term holders of Valeant stock as another line of defense, said one of the bankers.

A spokesperson for Valeant said Valeant does not have any timeline under which Allergan must respond to the new bid. When asked about alternative acquisition plans, the spokesperson said Valeant continues to seek out acquisitions.

Ronny Gal, a senior analyst at Bernstein Research, said in a research note that Valeant’s offer continues to underestimate the value of Allergan as a stand-alone entity. Valeant thinks Allergan shareholders will continue to believe the stock will decline to its pre-offer range of USD 120 to USD 130 if Allergan does not respond to the Valeant bid. But the analyst said he doubted such a decline is likely. The stock might slide to USD 140 but will then rebound immediately, said the analyst. The price at the end of 28 May was USD 165.

Valeant only wants to commit to developing one DARPin product, Gal said. Wet AMD is a competitive space, with multiple follow-on programs likely to raise the therapeutic bar in 2020. To be successful, Allergan and Valeant will need to commit to continue to develop product in this category. He added that “it is precisely the product that does not fit into the Valeant business model. We think that if Valeant succeeds in acquiring Allergan, this is the one program that they should sell, as it will wither under the Valeant model."

Allergan, investor Pershing Square, and its CEO Bill Ackman declined to comment for this story.

>>> Cepsa could offer EUR 700m for Salamander Energy, may seek financial partner

Cepsa could offer EUR 700m for Salamander Energy, may seek financial partner 

The offer that Compañia Española de Petróleos (Cepsa) is mulling for Salamander Energy [LON SMDR] amounts to EUR 700m including debt, Expansion reported citing market sources. The amount includes EUR 500m (GBP 350m) for the company and EUR 200m debt.

Cepsa could make the offer jointly with a financial partner, the report said. No agreement has been reached yet, the report's sources said.

On Wednesday this news service identified Cepsa as the bidder for Salamander Energy, following reports last week that Salamander had received a cash offer for the whole company at around GBP 144 per share.

Salamander fits the strategy of Abu Dhabi’s International Petroleum Investment Company to use Cepsa as a vehicle to invest outside the Middle East, Expansion said.

Sources from Cepsa and Salamander Energy declined to comment, the report said.


Source Expansion

>>> Telecom Italia shareholder calls for merger via incorporation of GVT

Telecom Italia shareholder calls for merger via incorporation of GVT 

Marco Fossati, the owner of Findim, the holding that controls 5% of Telecom Italia (TI), has called for TI to carry out merger through an incorporation with GVT, the Brazilian broadband operator.

In an interview with Italian-language daily Milano Finanza, Fossati said that such a merger would create synergies and add value as GVT is one of the few operators to offer broadband via cable rather than ADSL.

Fossati said that the operation would include both cash and share and also involve a small capital increase to ensure that TI continued to hold over 50% of Tim Brasil, its mobile phone subsidiary in Brazil.

Fossati added that he was not against a sale of Tim Brasil, as it would reduce debt and allow for important investments in Italy. However, Fossati added that such a sale could only be justified if an Italian project was drawn up which would create value for TI.

Fossati also welcomed the possible dissolution of Telco, the shareholder vehicle that controls TI with a 22.4% stake, as it would make TI more open to a takeover. Telco, which is owned by the Spanish telco Telefonica, Generali, Mediobanca and Intesa Sanpaolo, could be dissolved in June, the article noted.

A report in La Repubblica cited financial sources who said that TI's CEO, Marco Patuano, and Tim Brasil's CEO, Rodrigo Abreu, had met with senior GVT management to discuss a merger with between Tim Brasil and GVT.

The report noted that GVT is controlled by the French telco Vivendi.


Source Milano Finanza daily edition, La Repubblica

>>> Remy Cointreau +4% Yesterday on €90/shre bid from Brown-Forman (dailymail)

Intoxicating rumours of a €90 a share cash bid for Remy Cointreau did the rounds, lifting the Remy Martin cognac-to-Mount Gay rum group 3 per cent to €67.


Rumours have been rife recently that Brown-Forman, the US maker of Jack Daniel’s whiskey and owner of the Southern Comfort and Tequila Herradura brands, had approached the Heriard Dubreuil family, which owns a controlling 60 per cent stake in Remy, with terms on a ‘friendly’ cash bid. It was apparently sent away with a sozzled flea in its ear, but industry experts still believe underperformer Remy’s days of independence are definitely numbered.


Remy’s shares were trading at €96 a year ago, but plummeted to a low of €53 following a profits warning. The group has been hurt by a Chinese government crackdown on extravagant spending that hit sales of spirits. Sales of cognac fell 32 per cent in the final quarter of last year, following a 30 per cent drop in sales during the third-quarter. Cognac makes up 80 per cent of Remy’s operating profits, and China was 50 per cent of that total.


Brown-Forman’s reported interest in Remy could flush out other predators. Diageo’s (24p better at 1904.5p) chief executive Ivan Menezes earlier this year lost out on US bourbon producer Beam, which was swallowed by Japanese whisky maker Suntory in a £9.6billion deal. He could step in for Remy to prevent yet more famous brands from falling into rivals’ hands and to consolidate the group’s position as the world’s number one spirits group by sales.


Follow us: @MailOnline on Twitter | DailyMail on Facebook

>>> Japan govt to support domestic efforts to launch 5G mobile n

Japan govt to support domestic efforts to launch 5G mobile network service by 2020, ahead of other countries - Nikkei
- Japan Communications Ministry to meet with major telecom companies as well as handset manufacturers as early as this year to discuss development of 5G technologies. 
- Report further noting that carriers are seen beginning to offer 4G service around 2016 using spectrum to be allocated later this year.

>>> Asian Update

Asian Market Update: Japan downgrades assessment of industrial production after a miss in data; CPIs hit new multi-year highs

***Economic Data*** - (JP) JAPAN APR PRELIMINARY INDUSTRIAL PRODUCTION M/M: -2.5% V -2.0%E; Y/Y: 4.1% V 4.5%E; Japan DOWNGRADES assessment on industrial production to "output flattening as a trend" - (JP) JAPAN MAY TOKYO CPI Y/Y: 3.1% V 3.0%E; CPI CORE Y/Y: 2.8% V 2.9%E (fastest annual gain since Apr 1992) - (JP) JAPAN APR NATIONAL CPI Y/Y: 3.4% (highest since Feb 1991) V 3.4%E; CPI CORE Y/Y: 3.2% (multi-year high) V 3.1%E - (JP) JAPAN APR JOBLESS RATE: 3.6% V 3.6%E; JOB-TO-APPLICANT RATIO: 1.08 V 1.07E - (JP) JAPAN APR OVERALL HOUSEHOLD SPENDING Y/Y: -4.6% V -3.4%E (1st decline in two months) - (JP) JAPAN APR LOANS & DISCOUNT CORP: 2.3% V 1.9% PRIOR - (AU) AUSTRALIA APR PRIVATE SECTOR CREDIT M/M: 0.5% (4-month high) V 0.4%E; Y/Y: 4.6% V 4.5%E - (NZ) NEW ZEALAND APR BUILDING PERMITS M/M: +1.5% V -3.5%E (2nd consecutive monthly gain) - (NZ) NEW ZEALAND APR MONEY SUPPLY M3 Y/Y: 5.3% V 5.0% PRIOR - (SG) SINGAPORE APR CREDIT CARD BAD DEBTS: 21.6M V 21.8M PRIOR; CREDIT CARD BILLINGS: 3.5B V 3.7B PRIOR - (SG) SINGAPORE APR MONEY SUPPLY M1 Y/Y: 4.8% V 6.9% PRIOR; M2 Y/Y: 1.4% V 2.0% PRIOR - (SG) SINGAPORE APR BANK LOANS AND ADVANCES: 13.2% V 13.5% PRIOR - (KR) SOUTH KOREA APR INDUSTRIAL PRODUCTION M/M: 0.1% V 0.5%E; Y/Y: 2.4% V 3.1%E - (KR) SOUTH KOREA JUN MANUFACTURING BUSINESS SURVEY: 81 V 86 PRIOR; NON-MANUFACTURING SURVEY: 72 V 74 PRIOR - (KR) SOUTH KOREA APR CYCLICAL LEADING INDEX CHANGE Y/Y: +0.1% V -0.2% PRIOR - (UK) UK MAY GFK CONSUMER CONFIDENCE: 0 V -2E (first non-negative reading since Mar 2005)

Market Snapshot (as of 03:30 GMT): - Nikkei225 -0.5%, S&P/ASX -0.2%, Kospi-0.3%, Shanghai Composite -0.1%, Hang Seng +0.3%, Jun S&P500 -0.2% at 1,915, Aug gold +0.1% at $1,258, Jul crude oil -0.2% at $103.38/brl

***Highlights/Observations/Insights*** - A raft of economic data out of Japan was largely mixed, with bigger than expected drop in industrial production balanced by multi-year high CPI figures. The miss in industrial output prompted the govt to lower its economic assessment on the sector to "flattening as a trend." Recall the last time BOJ announced its policy statement, it reiterated industrial production is on a moderate increasing trend. Japan CPIs remained elevated, with Core prints hitting multi-year highs on both nationwide and Tokyo-region basis. Note however that the CPIs account for the impact of consumption tax increase being passed on to consumers, and analysts are divided to what extent the stripped-out for VAT version meets the BOJ's 2% target. Govt spokesperson Suga said prices are moving in line with govt expectations. Nikkei225 is underperforming while USD/JPY traded softer for much of the session, falling about 25pips from opening highs to around ¥101.50.

- Korean Won continued to strengthen, with USD/KRW opening onshore trade below KRW1,020 - its firmest level since late 2008. Unconfirmed speculation of an intervention from the BOK sent the pair back to KRW1,021. Also of note in the currency market, NZD outperformed after a better than expected Building Approvals data, rising back above the $0.85 handle after a sharp decline earlier this week.

- In China, the Banking Regulator surmised that the risks in the property sector were controllable, while the PBoC eased up on a trend of softer settings for the currency midpoint rate going into the weekend. On Sunday, China will release its official Manufacturing PMI expected to rise for the 3rd consecutive month.

***Speakers/Political/In the Papers*** - (CN) China Banking Regulatory Commission (CBRC): Overall property loan risk controllable - financial press - (CN) Nomura economist Zhang: Economy still faces downward pressure; Difficulties cannot be underestimated - Shanghai Daily - (CN) Barclays: estimates China shadow banking reached CNY38.8T; Sees higher chance to have more significant monetary easing - financial press - (JP) Japan Econ Min Amari: Japan economy on firm track to recover despite the sales tax hike - financial press - (JP) Japan Chief Cabinet Sec Suga: Prices are moving in line with govt expectations - financial press - (JP) Japan Fin Min Aso: Q2 economic slowdown likely to be smaller than expectations; sees Q3 pick up to be fast - financial press - (US) Fed's George (non voter, hawk): Fed should raise rates shortly after the end of bond buying; open to possibility of keeping balance sheet large - policy conf (Stanford CA) - (GR) Greece opposition Syriza party leader Tsipras: May not adhere to the agreement on Greek debt relief - financial press

***Fixed Income/Commodities/Currencies*** - (JP) BOJ offers to buy ¥250B in 1-3yr JGB, ¥250B in 3-5yr JGB and ¥400B in 5-10yr JGB as well as ¥2.0T in T-bills - (AU) Australia MoF (AOFM) sells A$700M in 2018 Bonds; avg yield: 3.0600%; bid-to-cover: 5.93x - (US) Weekly Fed Balance Sheet Total Assets Week ending May 28th: $4.32T v $4.33T prior; Reserve Bank Credit: $4.28T v $4.28T prior; M1: -$11.0B (2nd consecutive decline) v -$23.3B prior; M2: +$5.0B (4th consecutive increase) v +$4.6B prior; M1 y/y change: 10.6% (9-month high) v 10.5% w/w; M2 y/y change: 6.2% v 6.3% w/w - USD/CNY: (CN) PBoC sets yuan mid point at 6.1695 v 6.1705 prior setting (1st firmer Yuan setting in three sessions)

***Equities*** US extended session notables: - RTRX: Enters into US License Agreement for Thiola (Tiopronin); raises FY14 Rev guidance to $30-35M v $20Me (1est; $20-22M prior); +27.7% afterhours - OVTI: Reports Q4 $0.40 v $0.27e, R$331M v $289Me; +17.4% afterhours - CRM: Microsoft and salesforce.com confirm global, strategic partnership; Terms of the deal were not disclosed; +1.9% afterhours - GES: Reports Q1 -$0.03 v -$0.06e, R$522.5M v $522Me; -3.3% afterhours - SPLK: Reports Q1 -$0.04 v -$0.06e, R$85.9M v $80.4Me; -9.5% afterhours - PSUN: Reports Q1 -$0.11 v -$0.13e, R$171.1M v $171Me; -9.9% afterhours - EXPR: Reports Q1 $0.06 v $0.14e, R$460.7M v $481Me; Approves $100M share repurchase (8.8% of market cap); -11.5% afterhours - BNNY: Reports Q4 $0.29 v $0.35e, R$60.1M v $61.1Me; -17.4% afterhours - BLOX: Reports Q3 $0.07 v $0.03e, R$61M v $62.5Me; -29.8% afterhours

Asia movers by sector: - Technology: Yonyou Software 600588.CN +3.9% (China govt support of software industry); Toshiba 6502.JP +1.5% (S&P outlook) - Materials: Aquila Resources AQA.AU +0.4% (Australia approves Baosteel's takeover bid); Yancoal Australia YAL.AU -7.4% (Chairman comments of market conditions) - Financials: Australand ALZ.AU +2.1% (Raises guidance; to cooperate with Stockland on due dilligence); Cheung Kong Holdings 1.HK +1.8%, Power Assets Holdings 6.HK +0.8% (JV announcement) - Telecom: KDDI 9433.JP +0.2% (voice plan)

>>> US After Hours

After Hours Summary: RTRX +28.9%, OVTI +17.8%, VEEV +6.2%, BLOX -28.6%, ENVI -21.8%, BNNY -16.9%, EXPR -10.3% following earnings/guidance

After Hours Gainers: Companies trading higher in after hours in reaction to earnings: RTRX +28.9%, OVTI +17.8%, VEEV +6.2%, NMBL +3.8%, VMEM +1.7%, AVGO +1.5%

Companies trading higher in after hours in reaction to news: RTRX +28.9% (announced entry into a U.S. license agreement for Thola (tiopronin); co also increased its FY14 and FY15 guidance and announced a new $80 mln term loan and convertible note issuance), NBY +17.0% (continued strength on reports that co's NeutraPhase product was used to treat necrotizing fasciitis), AVA +5.0% (announced its non-regulated subsidiary, Avista Capital, signed an agreement to sell Ecova, Inc. to Cofely USA Inc. for $335 mln in cash), GTE +2.2% (announced entry into an agreement to sell its Argentina business for ~$69 mln), LCI +2.1% (to replace ZLC in the S&P SmallCap 600), CRM +1.5% (announced global strategic partnership with Microsoft (MSFT)), VMEM +1.7% (announced agreement to sell its PCIe product line for ~ $23 mln in cash and the assumption of certain liabilities totaling $0.5 mln; co also reported earnings)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: BLOX -28.6%, ENVI -21.8%, BNNY -16.9%, EXPR -10.3%, PSUN -9.9%, SPLK -9.5%, UQM -8.5%, LGF -6%, FWM -3.6%, GES -3.1%

Companies trading lower in after hours in reaction to news: BLOX -28.6% (Co's CEO Robert Thomas to step down; co also reported earnings), GLUU -8.1% (announced proposed public offering of common stock), CRDS -5.6% (filed for $25 mln mixed securities shelf offering; also files for ~2.98 mln share common stock offering by selling shareholders), MDW -5.0% (announced $25 mln bought deal offering of 30.121 mln common shares at $0.83 per share)